RAINBOW · Rainbow Childrens Medicare Ltd · Healthcare Facilities
RAINBOW · Rainbow Childrens Medicare Ltd · Healthcare Facilities
As of 06 Nov close
52-week range
22.7% below 52-week high
52-week range: as of 06 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Revenue (latest Q)
₹470 Cr
Revenue YoY
PAT YoY
+13.2%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
8.8
P/S (TTM)
6.9
Sector P/E
29
Dividend yield
+0.3%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| RAINBOW (this stock) | 50.3 | 8.8 | +15.7% | +17.3% | 0.54 | +0.3% |
| Apollo Hospitals Enterprise | 63.9 | 13.2 | +7.8% | +21.9% | 53.8 | +0.2% |
| Max Healthcare Institute | 68.4 | 9.5 | +17.2% | +14.3% | 27.71 | +0.2% |
| Fortis Healthcare | 69 | 14.6 | +11.0% | +10.6% | 0.35 | +0.1% |
Promoter
stable
FII
falling 3q
MF
18.53% (+1.07pp)
rising 3q
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: During the earnings call for Q1 FY 2026-27, management reported a 33% year-on-year revenue growth, driven by contributions from both mature and newly commissioned hospitals. EBITDA grew by 29.9%, reflecting operational discipline and efficiency improvements. Management highlighted the successful rescue of critically ill pediatric patients as a testament to their clinical capabilities. They announced plans to expand bed capacity by 2,500 beds over the next five years, with a focus on entering new markets such as Mumbai and strengthening their presence in Andhra Pradesh. The company maintained a strong balance sheet with cash and equivalents of INR 613 crores. Management expressed confidence in achieving revenue growth of around 20% in the upcoming quarters, despite potential challenges from market dynamics. They emphasized the importance of integrating new acquisitions and enhancing digital capabilities to drive patient engagement and operational efficiency.
Management emphasized strong growth and successful clinical outcomes.
Sourced from an exchange-filed transcript, dated 04 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation by Rainbow Children's Medicare Limited, dated July 30, 2026, provided an overview of the company's unaudited financial results for the quarter ending June 30, 2026. The presentation highlighted the company's growth trajectory, including the expansion of its hospital network to 24 hospitals across 9 cities, and the successful acquisition of two hospitals. Management reported a year-on-year revenue increase of 33% to INR 4,699.9 million, with a profit after tax of INR 625.4 million, reflecting a 16% growth. The presentation emphasized the company's commitment to high standards of pediatric and obstetric care, supported by a unique doctor engagement model and a hub-and-spoke operational strategy. Additionally, Rainbow's hospitals received multiple accreditations, reinforcing its reputation in pediatric healthcare. The document concluded with a summary of the company's mission and vision, focusing on delivering exceptional care to mothers and children.
Management emphasized growth and achievements in the presentation.
Sourced from an exchange-filed presentation, dated 30 Jul 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the earnings call for Q4 FY26, management reported that FY26 was a landmark year for Rainbow Children's Medicare Limited, with the addition of nearly 500 beds, the highest in its history. The company achieved its highest quarterly revenue of INR 459.9 crores, reflecting a 24% year-on-year growth, and a PAT of INR 78.2 crores, up 38% from the previous year. Key operating metrics showed healthy growth in outpatient footfalls, inpatient discharges, and deliveries. Management highlighted successful integration of acquired hospitals and strong performance in newly commissioned facilities. They emphasized a focus on improving occupancies and clinical excellence as they enter the next growth phase. The company also maintained a strong balance sheet with INR 594 crores in liquidity. Future expansion plans include several new hospitals across various regions, with a commitment to maintaining a conservative capital structure.
Management emphasized strong growth and successful expansion initiatives.
Sourced from an exchange-filed transcript, dated 01 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation from Rainbow Children's Medicare Limited detailed the audited financial results for the quarter and financial year ended March 31, 2026. The company reported a revenue of INR 4,599 million for Q4 FY26, reflecting a 24% year-over-year increase. The profit for the year was INR 782 million, up 38% from the previous year. The presentation highlighted the company's extensive network of 241 hospitals across 9 cities, with a total bed capacity of 2,435. Management emphasized their hub-and-spoke model for healthcare delivery, which aims to enhance operational efficiencies and patient care. The document also noted the company's commitment to high governance standards and its unique doctor engagement model, which fosters loyalty and sustainability. Additionally, Rainbow's expansion plans include new hospitals and IVF centers, further solidifying its position in the pediatric and perinatal care sectors.
Management highlighted strong financial growth and expansion plans.
Sourced from an exchange-filed presentation, dated 23 May 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedRainbow Children's Medicare Limited (RAINBOW) reported FY2026 financials with a focus on expansion and standardization. The company incurred no R&D expenditure during the year. A significant contingent liability arises from a loan of ₹315.02 million to Madhukar Rainbow Children’s Hospital, with ₹111.54 million in accrued interest, due to the borrower's insufficient cash profits. The auditor highlighted this as a key audit matter, noting the risk of recoverability. No regulatory actions, defaults, or insolvency proceedings were reported. The company maintains adequate internal controls and complies with corporate governance standards.
- No R&D expenditure incurred in FY2026.
- Contingent liability of ₹315.02 million (including ₹111.54 million interest) from a loan to Madhukar Rainbow Children’s Hospital, with risk of recoverability.
- No regulatory actions, defaults, or insolvency proceedings reported.
- Adequate internal controls and compliance with corporate governance standards.
Key takeaway: Rainbow Children's Medicare Limited faces a significant contingent liability from a loan to Madhukar Rainbow Children’s Hospital, but no regulatory or insolvency issues were reported, with strong internal controls in place.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Default / Covenant Breach (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Default / Covenant Breach
1 occurrenceRecent (last 12 months)
The company has outstanding luxury tax dues of 8.30 million under the Andhra Pradesh Tax on Luxuries Act, 1987, with a dispute pending in the High Court of Telangana relating to the financial years 2010-11 to 2013-14.
Routine disclosures
Contingent Liability
2 occurrencesRecent (last 12 months)
The company is involved in disputes, lawsuits, and claims from patients/patient relatives, including income-tax and goods and services tax matters, and luxury tax demands under dispute, as of 31 March 2026.
Earlier (1-3 years ago)
The company has contingent liabilities related to disputes including income-tax matters, goods and services tax, and luxury tax demands under dispute, as well as medico-legal claims from patients or relatives. These are disclosed as contingent liabilities in the financial statements.
Related-Party Transaction
2 occurrencesRecent (last 12 months)
The company had significant related party transactions during the year, including revenue from medical services, pharmacy sales, and baby products to entities like Rainbow Children’s Foundation and Rosewalk Healthcare Private Limited, and professional services received from Ravindranath GE Medical Associates Private Limited and Unimed Healthcare Private Limited.
Earlier (1-3 years ago)
The company reported revenue from medical/professional services and pharmacy sales to Rainbow Children’s Foundation (Trust), Rainbow Speciality Hospitals Private Limited, Rosewalk Healthcare Private Limited, and other entities, as well as professional services received from Ravindranath GE Medical Associates Private Limited and Unimed Healthcare Private Limited during the year ended 31 March 2024.
Statutory dues in dispute
1 occurrenceEarlier (1-3 years ago)
The company has disputes over statutory dues under the Andhra Pradesh Tax on Luxuries Act, 1987 and the Income Tax Act, 1961, with amounts of 18.55 million Rs (partially paid) and pending disputes in the High Court of Telangana and Joint Commissioner (Appeals) respectively.
Management & Board Governance
1 occurrenceEarlier (1-3 years ago)
Mr. R. Gowrisankar, the Chief Financial Officer, resigned effective 31 May 2023. Mr. Vikas Maheshwari was appointed as the new CFO effective 01 June 2023.